In this episode, Dr. Julie Schulz, Vice President of Product at Avalon Healthcare Solutions, explores how bringing diagnostics to the center of value-based care can transform both clinical and financial performance. She highlights a growing challenge: physicians are facing unprecedented complexity from the surge in genetic testing and constantly shifting guidelines. This overload not only strains clinicians but also slows care.
Dr. Schulz explains how diagnostic intelligence serves as a remedy, pinpointing the most appropriate tests, streamlining prior authorization, and shrinking care delays from roughly two months to just a couple of weeks. Since diagnostics guide the majority of medical decisions, she argues that using them strategically is essential for advancing health equity, strengthening preventive care, and improving patient access.
The conversation also emphasizes the power of simplifying data and embedding evidence-based support earlier in the care journey, enabling providers to make more confident, timely decisions.
Listen in to discover how diagnostic intelligence is redefining precision medicine and accelerating better outcomes for patients and health systems alike.
Tune in at The Beat Podcast.
